These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 34499916)
1. Evidence for ceramide induced cytotoxicity in retinal ganglion cells. Fan J; Liu J; Liu J; Chen C; Koutalos Y; Crosson CE Exp Eye Res; 2021 Oct; 211():108762. PubMed ID: 34499916 [TBL] [Abstract][Full Text] [Related]
2. Lack of ceramide synthase 5 protects retinal ganglion cells from ocular hypertensive injury. Liu J; Koutalos Y; Fan J Exp Eye Res; 2024 Oct; 247():110061. PubMed ID: 39182597 [TBL] [Abstract][Full Text] [Related]
3. Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia. Fan J; Liu J; Liu J; Angel PM; Drake RR; Wu Y; Fan H; Koutalos Y; Crosson CE Exp Eye Res; 2022 Nov; 224():109250. PubMed ID: 36122624 [TBL] [Abstract][Full Text] [Related]
4. Suppression of Acid Sphingomyelinase Protects the Retina from Ischemic Injury. Fan J; Wu BX; Crosson CE Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4476-84. PubMed ID: 27571014 [TBL] [Abstract][Full Text] [Related]
5. Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model. Abdul Y; Akhter N; Husain S Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1816-28. PubMed ID: 23404122 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death. Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173 [TBL] [Abstract][Full Text] [Related]
7. Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model. Husain S; Abdul Y; Crosson CE Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4289-98. PubMed ID: 22661469 [TBL] [Abstract][Full Text] [Related]
8. Activation of P2X Zhang Y; Xu Y; Sun Q; Xue S; Guan H; Ji M Exp Eye Res; 2019 Nov; 188():107771. PubMed ID: 31445901 [TBL] [Abstract][Full Text] [Related]
9. Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension. Alsarraf O; Fan J; Dahrouj M; Chou CJ; Yates PW; Crosson CE Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7486-93. PubMed ID: 25358731 [TBL] [Abstract][Full Text] [Related]
10. JUN is important for ocular hypertension-induced retinal ganglion cell degeneration. Syc-Mazurek SB; Fernandes KA; Libby RT Cell Death Dis; 2017 Jul; 8(7):e2945. PubMed ID: 28726785 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha mediates activation of NF-κB and JNK signaling cascades in retinal ganglion cells and astrocytes in opposite ways. Dvoriantchikova G; Ivanov D Eur J Neurosci; 2014 Oct; 40(8):3171-8. PubMed ID: 25160799 [TBL] [Abstract][Full Text] [Related]
12. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma. Zhu Y; Zhang L; Gidday JM Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330 [TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection. Husain S; Ahmad A; Singh S; Peterseim C; Abdul Y; Nutaitis MJ Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6489-6499. PubMed ID: 29288267 [TBL] [Abstract][Full Text] [Related]
14. Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location. Feng L; Zhao Y; Yoshida M; Chen H; Yang JF; Kim TS; Cang J; Troy JB; Liu X Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1106-17. PubMed ID: 23322576 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension. Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect against axonal damage-induced retinal ganglion cell death in apolipoprotein E-deficient mice through the suppression of kainate receptor signaling. Omodaka K; Nishiguchi KM; Yasuda M; Tanaka Y; Sato K; Nakamura O; Maruyama K; Nakazawa T Brain Res; 2014 Oct; 1586():203-12. PubMed ID: 25160129 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin mediates mTOR signaling in reactive astrocytes and reduces retinal ganglion cell loss. Li N; Wang F; Zhang Q; Jin M; Lu Y; Chen S; Guo C; Zhang X Exp Eye Res; 2018 Nov; 176():10-19. PubMed ID: 29928901 [TBL] [Abstract][Full Text] [Related]
18. Assessment of inner retina dysfunction and progressive ganglion cell loss in a mouse model of glaucoma. Pérez de Lara MJ; Santano C; Guzmán-Aránguez A; Valiente-Soriano FJ; Avilés-Trigueros M; Vidal-Sanz M; de la Villa P; Pintor J Exp Eye Res; 2014 May; 122():40-9. PubMed ID: 24631335 [TBL] [Abstract][Full Text] [Related]
19. In glaucoma the upregulated truncated TrkC.T1 receptor isoform in glia causes increased TNF-alpha production, leading to retinal ganglion cell death. Bai Y; Shi Z; Zhuo Y; Liu J; Malakhov A; Ko E; Burgess K; Schaefer H; Esteban PF; Tessarollo L; Saragovi HU Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6639-51. PubMed ID: 20574020 [TBL] [Abstract][Full Text] [Related]
20. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma. Gallego BI; Salazar JJ; de Hoz R; Rojas B; Ramírez AI; Salinas-Navarro M; Ortín-Martínez A; Valiente-Soriano FJ; Avilés-Trigueros M; Villegas-Perez MP; Vidal-Sanz M; Triviño A; Ramírez JM J Neuroinflammation; 2012 May; 9():92. PubMed ID: 22583833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]